iGENETECH received the Impact Award at the 'Global ImpactPreneur 2026' Demo Day, held on July 7, 2026 at Ondream Society in Myeongdong, Seoul.
The Asia-Pacific impact startup program is co-hosted by the UNDP Seoul Policy Centre and the Hyundai Motor Chung Mong-Koo Foundation, and organized by Impact Square. This year, 20 teams selected from 10 Asia-Pacific countries went through three months of online acceleration, and following a June IR review, 10 finalists from five countries — Korea, Thailand, Cambodia, Malaysia, and Indonesia — advanced to the final stage.
Competing in the healthcare category, iGENETECH presented its portable molecular diagnostics platform designed for use in developing regions that lack large hospitals or established testing infrastructure, drawing attention as a solution to close gaps in diagnostic access. The award recognizes iGENETECH's potential to deliver meaningful global health impact through a sustainable business model.
Related coverage
- The Better Future: https://futurechosun.com/archives/154145
- Hyundai Motor Group Newsroom: https://www.hyundaimotorgroup.com/ko/news/hyundai-motor-company-chung-mong-koo-foundation-undp-asia-pacific-impact-preneur-demo-day
- Platum: https://platum.kr/archives/290540
iGENETECH received the Impact Award at the 'Global ImpactPreneur 2026' Demo Day, held on July 7, 2026 at Ondream Society in Myeongdong, Seoul.
The Asia-Pacific impact startup program is co-hosted by the UNDP Seoul Policy Centre and the Hyundai Motor Chung Mong-Koo Foundation, and organized by Impact Square. This year, 20 teams selected from 10 Asia-Pacific countries went through three months of online acceleration, and following a June IR review, 10 finalists from five countries — Korea, Thailand, Cambodia, Malaysia, and Indonesia — advanced to the final stage.
Competing in the healthcare category, iGENETECH presented its portable molecular diagnostics platform designed for use in developing regions that lack large hospitals or established testing infrastructure, drawing attention as a solution to close gaps in diagnostic access. The award recognizes iGENETECH's potential to deliver meaningful global health impact through a sustainable business model.
Related coverage